BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9551649)

  • 1. Infrared microspectroscopy and artificial neural networks in the diagnosis of cervical cancer.
    Romeo M; Burden F; Quinn M; Wood B; McNaughton D
    Cell Mol Biol (Noisy-le-grand); 1998 Feb; 44(1):179-87. PubMed ID: 9551649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic value of computer-assisted primary cervical smear screening: a longitudinal cohort study.
    Doornewaard H; van der Schouw YT; van der Graaf Y; Bos AB; Habbema JD; van den Tweel JG
    Mod Pathol; 1999 Nov; 12(11):995-1000. PubMed ID: 10574595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of benign cellular changes in diagnosis of cervical cancer using IR microspectroscopy.
    Romeo MJ; Quinn MA; Burden FR; McNaughton D
    Biopolymers; 2002; 67(4-5):362-6. PubMed ID: 12012467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Pap smear.
    Colyar MR
    Adv Nurse Pract; 2002 Jul; 10(7):22. PubMed ID: 12420546
    [No Abstract]   [Full Text] [Related]  

  • 5. [Follow up after an abnormal pap smear: time interval acceptable, nature of follow up leaves room for improvement].
    Geertsen M; Bais AG; Beerman H; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2430-4. PubMed ID: 14694554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of blood components from cervical smears: implications for cancer diagnosis using FTIR spectroscopy.
    Romeo MJ; Wood BR; Quinn MA; McNaughton D
    Biopolymers; 2003; 72(1):69-76. PubMed ID: 12400093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis of cervical dysplasias].
    Pérez Dettoma J; Santamaría M; Jurado M; Cabezón C; Domínquez J; de la Fuente F; López García G
    Rev Med Univ Navarra; 1980 Dec; 24(4):26-9. PubMed ID: 7336009
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignancy associated changes in cervical smears: systematic changes in cytometric features with the grade of dysplasia.
    Guillaud M; Doudkine A; Garner D; MacAulay C; Palcic B
    Anal Cell Pathol; 1995 Oct; 9(3):191-204. PubMed ID: 8562458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Season, sun, sex, and cervical cancer.
    Hrushesky WJ; Sothern RB; Rietveld WJ; Du Quiton J; Boon ME
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1940-7. PubMed ID: 16103441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reinvestigation of crucial cases where first diagnosis by mailing smear test disagrees with second diagnosis by cytology and/or biopsy.
    Noda S; Terakawa N; Abe Y
    Acta Obstet Gynaecol Jpn; 1976 Jul; 23(3):173-8. PubMed ID: 1026045
    [No Abstract]   [Full Text] [Related]  

  • 11. PAPNET for analysis of proliferating (MIB-1 positive) cell populations in cervical smears.
    Boon ME; Kleinschmidt-Guy ED; Ouwerkerk-Noordam E
    Eur J Morphol; 1994 Mar; 32(1):78-85. PubMed ID: 8086271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational approaches to improving cervical screening.
    Baldwin P; Laskey R; Coleman N
    Nat Rev Cancer; 2003 Mar; 3(3):217-26. PubMed ID: 12612656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is the end of the Pap classification in sight?].
    Boon ME; Bosch MM
    Ned Tijdschr Geneeskd; 1990 May; 134(20):1016-8. PubMed ID: 2348893
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of compound aminopyrine phenacetin tablets by using artificial neural networks combined with principal components analysis.
    Dou Y; Mi H; Zhao L; Ren Y; Ren Y
    Anal Biochem; 2006 Apr; 351(2):174-80. PubMed ID: 16359633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytologic screening for cancer of the uterine cervix. "The debate of 1980s".
    Yoonessi M; Yip J; Sullivan A
    Diagn Gynecol Obstet; 1981; 3(1):5-8. PubMed ID: 7215125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cervical intraepithelial neoplasia. A practical point of view].
    Sánchez Guzmán JI
    Ginecol Obstet Mex; 1979 Aug; 46(274):139-40. PubMed ID: 520855
    [No Abstract]   [Full Text] [Related]  

  • 17. [The cytological diagnosis of mild and moderate dysplasia, an analysis of validity and practicability of class IIID (author's transl)].
    Sander H; Kattner W; Soost HJ
    Geburtshilfe Frauenheilkd; 1978 Sep; 38(9):726-34. PubMed ID: 680551
    [No Abstract]   [Full Text] [Related]  

  • 18. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
    Singh M; Prasad S; Kalra N; Singh U; Shukla Y
    Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infrared spectroscopy of normal and abnormal cervical smears: evaluation by principal component analysis.
    Cohenford MA; Godwin TA; Cahn F; Bhandare P; Caputo TA; Rigas B
    Gynecol Oncol; 1997 Jul; 66(1):59-65. PubMed ID: 9234922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suitability of infrared microspectroscopic imaging for histopathology of the uterine cervix.
    Einenkel J; Braumann UD; Steller W; Binder H; Horn LC
    Histopathology; 2012 Jun; 60(7):1084-98. PubMed ID: 22372426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.